Cellectis (CLLS) Income from Continuing Operations (2016 - 2023)
Historic Income from Continuing Operations for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to -$14.1 million.
- Cellectis' Income from Continuing Operations rose 3954.64% to -$14.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$40.4 million, marking a year-over-year increase of 4435.07%. This contributed to the annual value of -$80.8 million for FY2022, which is 13379.63% down from last year.
- As of Q3 2023, Cellectis' Income from Continuing Operations stood at -$14.1 million, which was up 3954.64% from $3.1 million recorded in Q2 2023.
- Cellectis' Income from Continuing Operations' 5-year high stood at $14.4 million during Q1 2020, with a 5-year trough of -$42.4 million in Q3 2021.
- For the 5-year period, Cellectis' Income from Continuing Operations averaged around -$22.3 million, with its median value being -$23.4 million (2022).
- As far as peak fluctuations go, Cellectis' Income from Continuing Operations soared by 16233.83% in 2020, and later plummeted by 23812.79% in 2021.
- Quarter analysis of 5 years shows Cellectis' Income from Continuing Operations stood at -$38.5 million in 2019, then decreased by 1.74% to -$39.2 million in 2020, then skyrocketed by 79.39% to -$8.1 million in 2021, then plummeted by 47.88% to -$11.9 million in 2022, then decreased by 18.34% to -$14.1 million in 2023.
- Its last three reported values are -$14.1 million in Q3 2023, $3.1 million for Q2 2023, and -$17.5 million during Q1 2023.